rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
14	Lupus anticoagulant disorder	C0311370	3	26	1.08734909965e-10	1.3195098963242225e-05	SERPINC1,F2,SELP
15	Pulmonary hypertension, neonatal, susceptibility to	C0020542	5	333	1.19139587085e-10	1.413760603204524e-05	MYC,F2,JUN,SELP,FOS
20	Factor V Leiden mutation	C0584960	3	56	1.43158085386e-09	1.885014137606032e-05	SERPINC1,F2,SELP
21	Verotoxigenic Escherichia coli gastrointestinal tract infection	C0009450	6	1111	2.19999518603e-09	1.9792648444863336e-05	MYC,SERPINC1,F2,JUN,SELP,FOS
22	Restenosis	C0333186	4	220	2.4424081646e-09	2.0735155513666354e-05	MYC,F2,JUN,FOS
23	Scleroderma	C0036421	5	573	3.30020955008e-09	2.167766258246937e-05	MYC,F2,JUN,SELP,FOS
26	Anemia, Sickle Cell	C0002895	4	271	7.00952040855e-09	2.4505183788878417e-05	F2,JUN,SELP,FOS
28	Carcinoid tumor no ICD-O subtype	C0334299	3	87	8.64197702288e-09	2.639019792648445e-05	MYC,JUN,FOS
29	Coronary Artery Disease	C1956346	6	1366	9.28914400955e-09	2.7332704995287468e-05	MYC,SERPINC1,F2,UBC,SELP,FOS
30	Ischaemic cerebral infarction	C0007785	4	297	1.1081634721e-08	2.827521206409048e-05	SERPINC1,F2,JUN,FOS
31	Reperfusion Injury	C0035126	4	305	1.26481100038e-08	2.9217719132893498e-05	F2,JUN,SELP,FOS
33	Hereditary factor VIII deficiency disease	C0019069	3	105	1.84511749213e-08	3.110273327049953e-05	MYC,F2,SELP
35	Hypoxia	C0003130	4	335	2.02417385076e-08	3.298774740810556e-05	MYC,F2,JUN,FOS
37	Acute lymphoid leukemia	C0023449	5	824	2.89681436616e-08	3.48727615457116e-05	MYC,SERPINC1,F2,JUN,FOS
38	Thromboembolism	C0040038	3	118	2.96769583352e-08	3.581526861451461e-05	SERPINC1,F2,SELP
40	Septicemia	C0036690	4	387	4.14854903763e-08	3.770028275212064e-05	F2,JUN,SELP,FOS
41	Alzheimer Disease	C0002395	6	1699	4.22289456736e-08	3.864278982092366e-05	MYC,SERPINC1,F2,JUN,SELP,FOS
42	Scrub Typhus	C0036472	2	25	4.59424649435e-08	3.958529688972667e-05	JUN,FOS
43	Pulmonary Embolism	C0034065	3	133	4.79117092667e-08	4.0527803958529686e-05	SERPINC1,F2,SELP
44	Thrombophilia due to activated protein C resistance	C1861171	2	26	5.19336960103e-08	4.147031102733271e-05	SERPINC1,F2
45	Vascular Diseases	C0042373	4	410	5.53305077311e-08	4.241281809613572e-05	F2,JUN,SELP,FOS
46	Venous thrombosis	C0042487	3	142	6.24085285672e-08	4.335532516493874e-05	SERPINC1,F2,SELP
47	Homocystinuria due to CBS deficiency	C0019880	2	28	6.53997807021e-08	4.429783223374175e-05	SERPINC1,F2
48	Polycystic kidney disease, autosomal dominant	C0022680	3	147	7.17615167289e-08	4.5240339302544774e-05	MYC,JUN,FOS
49	Essential thrombocythemia	C0040028	3	150	7.78046327365e-08	4.618284637134779e-05	MYC,F2,SELP
50	Rheumatoid arthritis	C0003873	6	1856	7.80381106402e-08	4.71253534401508e-05	MYC,SERPINC1,F2,JUN,SELP,FOS
51	Protein S deficiency	C0242666	2	30	8.09695631654e-08	4.806786050895382e-05	SERPINC1,F2
52	Tumor Angiogenesis	C1519670	4	443	8.13760462348e-08	4.9010367577756834e-05	MYC,F2,JUN,FOS
73	Antithrombin III deficiency	C0272375	2	31	8.96195800903e-08	6.880301602262016e-05	SERPINC1,F2
74	Thrombosis	C0040053	3	157	9.34558654908e-08	6.97455230914232e-05	SERPINC1,F2,SELP
75	Polycystic Kidney, Autosomal Dominant	C0085413	3	158	9.58764203585e-08	7.06880301602262e-05	MYC,JUN,FOS
76	Reduced protein C activity	C0398625	2	32	9.89379990157e-08	7.163053722902922e-05	SERPINC1,F2
77	Arteriosclerosis	C0003850	5	1059	1.28771718955e-07	7.257304429783223e-05	MYC,SERPINC1,F2,SELP,FOS
78	Enteritis	C0014335	2	35	1.30487327388e-07	7.351555136663525e-05	JUN,FOS
79	Resistance to activated protein C	C0600433	2	35	1.30487327388e-07	7.445805843543826e-05	SERPINC1,F2
80	Eclampsia	C0013537	3	183	1.72880228133e-07	7.540056550424128e-05	F2,JUN,FOS
81	Carcinoid tumor	C0007095	3	183	1.72880228133e-07	7.63430725730443e-05	MYC,JUN,FOS
82	Clear cell sarcoma, of tendons and aponeuroses	C0206651	2	40	1.96745605696e-07	7.728557964184731e-05	MYC,FOS
83	Idiopathic crescentic glomerulonephritis	C0403416	2	41	2.12289973822e-07	7.822808671065034e-05	JUN,FOS
84	Fetal Membranes, Premature Rupture	C0015943	3	194	2.18545609942e-07	7.917059377945334e-05	SERPINC1,F2,SELP
85	Chorioamnionitis	C0008495	3	195	2.23008957967e-07	8.011310084825636e-05	SERPINC1,F2,SELP
86	Thrombotic Microangiopathies	C2717961	2	42	2.28573431849e-07	8.105560791705937e-05	F2,SELP
87	Erythroblastosis	C0272138	2	42	2.28573431849e-07	8.19981149858624e-05	JUN,FOS
88	Malignant Conversion	C1518171	2	42	2.28573431849e-07	8.294062205466542e-05	MYC,FOS
89	Deep vein thrombosis of lower limb	C0340708	2	43	2.456444127e-07	8.388312912346844e-05	SERPINC1,F2
90	Medullary thyroid carcinoma	C0238462	3	201	2.51836244525e-07	8.482563619227145e-05	MYC,JUN,FOS
104	Premature Obstetric Labor	C0022876	3	203	2.62035982357e-07	9.802073515551367e-05	SERPINC1,F2,SELP
105	Disseminated intravascular coagulation	C0012739	2	44	2.63636747322e-07	9.896324222431669e-05	SERPINC1,F2
106	Deep thrombophlebitis	C0151950	2	44	2.63636747322e-07	9.99057492931197e-05	SERPINC1,F2
107	Varicose Ulcer	C0042344	2	45	2.82367653592e-07	0.00010084825636192272	MYC,F2
108	Melanocytic nevus of skin	C3665593	2	47	3.22608664005e-07	0.00010179076343072573	MYC,FOS
109	Acute Cerebrovascular Accidents	C0751956	2	49	3.66398981377e-07	0.00010273327049952876	F2,SELP
110	Coronary Restenosis	C0948480	2	49	3.66398981377e-07	0.00010367577756833177	MYC,F2
111	Sepsis	C0243026	4	602	3.73356980332e-07	0.00010461828463713478	F2,JUN,SELP,FOS
112	Atherosclerosis	C0004153	5	1271	3.80085037444e-07	0.0001055607917059378	MYC,SERPINC1,F2,SELP,FOS
113	Cardiac arrest	C0018790	3	223	3.81610895328e-07	0.00010650329877474081	JUN,SELP,FOS
114	Neoplasm of the liver	C0023903	5	1290	4.14968109985e-07	0.00010744580584354383	MYC,SERPINC1,F2,JUN,FOS
115	Venous Thromboembolism	C1861172	3	240	5.11810541282e-07	0.00010838831291234684	SERPINC1,F2,SELP
126	Lymphoma, Large B-Cell, Diffuse	C0024299	5	1362	5.72312319425e-07	0.00011875589066918002	MYC,SERPINC1,UBC,JUN,FOS
127	Glucocorticoid resistance, generalized	C1841972	2	57	5.81294987478e-07	0.00011969839773798303	JUN,FOS
128	Cutaneous T-cell lymphoma	C0079773	3	255	6.52036839077e-07	0.00012064090480678605	MYC,JUN,FOS
129	Aortic valve disease 2	C3542024	2	60	6.79503925571e-07	0.00012158341187558906	JUN,FOS
130	Oropharyngeal Carcinoma	C2349952	2	60	6.79503925571e-07	0.00012252591894439208	JUN,FOS
131	Anaplastic large cell lymphoma, ALK negative	C0206180	3	263	7.37530206463e-07	0.0001234684260131951	MYC,JUN,FOS
132	Glomerulonephritis, Membranous	C0017658	3	267	7.83353829803e-07	0.00012441093308199812	JUN,SELP,FOS
133	Endometrial Neoplasms	C0014170	3	268	7.95123801689e-07	0.00012535344015080115	MYC,JUN,FOS
134	Cerebral ischemia	C0917798	3	272	8.43535181816e-07	0.00012629594721960417	F2,JUN,FOS
144	Lupus Erythematosus, Systemic	C0024141	5	1467	8.87699201924e-07	0.0001357210179076343	SERPINC1,F2,JUN,SELP,FOS
145	Hemangiosarcoma	C0018923	2	68	9.93991812304e-07	0.00013666352497643732	MYC,JUN
146	Shock, Septic	C0036974	2	69	1.03895535253e-06	0.00013760603204524032	MYC,F2
147	Hyperlipidemia, combined, 1	C0020473	3	293	1.13459337736e-06	0.00013854853911404337	F2,SELP,FOS
148	Coronary heart disease 7	C0010054	4	754	1.13724775352e-06	0.0001394910461828464	MYC,F2,SELP,FOS
149	 Cerebrovascular disease, occlusive (3)	C0007820	2	73	1.23267418317e-06	0.00014043355325164938	F2,SELP
155	Bleeding with minor or no trauma	C0019080	2	74	1.28453508208e-06	0.00014608859566446749	F2,FOS
156	Homocysteinemia due to MTHFR deficiency	C3495426	2	74	1.28453508208e-06	0.0001470311027332705	SERPINC1,F2
157	Complications of Diabetes Mellitus	C0342257	2	75	1.33782964906e-06	0.00014797360980207353	F2,SELP
158	Non-alcoholic Fatty Liver Disease	C0400966	3	317	1.5522091863e-06	0.00014891611687087652	F2,JUN,FOS
159	Abnormal thrombosis	C4025731	2	79	1.56583065569e-06	0.00014985862393967955	SERPINC1,F2
160	Acute Coronary Syndrome	C0948089	3	320	1.61151894307e-06	0.00015080113100848257	SERPINC1,F2,SELP
161	Benign melanocytic nevus	C1456781	2	80	1.62657037717e-06	0.0001517436380772856	MYC,FOS
162	Adenocarcinoma of lung	C0152013	4	815	1.66945069902e-06	0.0001526861451460886	MYC,JUN,SELP,FOS
163	Pregnancy loss	C0156543	2	81	1.68888115482e-06	0.0001536286522148916	SERPINC1,F2
164	Hypertension	C0020538	5	1647	1.75717734774e-06	0.00015457115928369463	SERPINC1,F2,JUN,SELP,FOS
175	Sarcoma, Ewing	C1261473	4	829	1.81561532364e-06	0.0001649387370405278	MYC,SERPINC1,JUN,FOS
176	Juvenile idiopathic arthritis, enthesitis related arthritis	C3495559	3	333	1.88806190449e-06	0.00016588124410933083	JUN,SELP,FOS
177	Candidiasis, familial, 9	C0006840	2	85	1.95395818359e-06	0.00016682375117813383	JUN,FOS
178	Ischemic Cerebrovascular Accident	C3272363	3	338	2.00333108924e-06	0.00016776625824693688	SERPINC1,F2,SELP
179	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	4	854	2.10191161409e-06	0.00016870876531573987	MYC,F2,JUN,FOS
180	Tumor Promotion	C1519689	2	88	2.17004136038e-06	0.0001696512723845429	JUN,FOS
181	Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy	C0852949	2	90	2.32243163012e-06	0.00017059377945334589	F2,SELP
190	Angina, Unstable	C0002965	2	92	2.48186635909e-06	0.00017907634307257305	F2,SELP
191	Arterial thrombosis	C0151942	2	94	2.64834268704e-06	0.00018001885014137605	F2,SELP
192	Prolactinoma, familial	C0033375	2	95	2.73428059128e-06	0.0001809613572101791	MYC,FOS
193	Hepatocellular carcinoma	C2239176	6	3108	2.76172394809e-06	0.0001819038642789821	MYC,SERPINC1,F2,UBC,JUN,FOS
194	Polyglandular autoimmune syndrome, type 1	C0085409	2	96	2.82206194346e-06	0.0001828463713477851	MYC,F2
195	Endotoxemia	C0376618	2	96	2.82206194346e-06	0.0001837888784165881	SERPINC1,F2
196	Preeclampsia/eclampsia 1	C0032914	3	371	2.90043629925e-06	0.00018473138548539116	SERPINC1,F2,SELP
197	Stomach Neoplasms	C0038356	4	916	2.96788716081e-06	0.00018567389255419418	MYC,F2,JUN,FOS
198	Liver Cirrhosis, Biliary	C0023890	4	919	3.0160127088e-06	0.00018661639962299717	MYC,F2,SELP,FOS
199	Thyroid Diseases	C0040128	3	376	3.05873854056e-06	0.0001875589066918002	MYC,JUN,FOS
200	Premature Birth	C0151526	3	376	3.05873854056e-06	0.0001885014137606032	SERPINC1,F2,SELP
206	Hepatitis	C0019159	3	377	3.09109116159e-06	0.00019415645617342132	MYC,F2,JUN
207	Pulmonary Disease, Chronic Obstructive	C0024115	3	377	3.09109116159e-06	0.0001950989632422243	F2,JUN,FOS
208	Heart Diseases	C0018799	3	386	3.39443897601e-06	0.00019604147031102733	MYC,F2,SELP
209	Abnormality of female internal genitalia	C4025900	3	398	3.83263366288e-06	0.00019698397737983033	MYC,F2,FOS
216	Ischemic stroke	C0948008	3	401	3.94846139828e-06	0.00020358152686145145	SERPINC1,F2,SELP
217	Severe Myopia	C0271183	2	109	4.13857593895e-06	0.00020452403393025448	JUN,FOS
218	Deep venous thrombosis	C0149871	2	112	4.49115216006e-06	0.00020546654099905752	SERPINC1,F2
219	Brain Ischemia	C0007786	3	415	4.52370143222e-06	0.00020640904806786052	F2,JUN,SELP
220	Abnormality of coagulation	C1846821	2	113	4.61301211929e-06	0.00020735155513666354	SERPINC1,F2
233	Myocardial Infarction	C0027051	4	1019	5.00974030126e-06	0.00021960414703110274	SERPINC1,F2,SELP,FOS
234	Abnormal internal genitalia	C4025824	3	426	5.01760374827e-06	0.00022054665409990576	MYC,F2,FOS
235	Hepatic steatosis	C0015695	3	427	5.06444153037e-06	0.00022148916116870876	MYC,F2,FOS
236	Cancer of Head and Neck	C0278996	3	430	5.20677296578e-06	0.00022243166823751178	JUN,SELP,FOS
237	Cardiovascular Diseases	C0007222	4	1029	5.25561791875e-06	0.0002233741753063148	F2,JUN,SELP,FOS
238	Glioma	C0017638	5	1997	5.45492167159e-06	0.00022431668237511782	MYC,F2,JUN,SELP,FOS
242	Liposarcoma	C0023827	2	122	5.80915376736e-06	0.00022808671065032988	MYC,JUN
243	Abnormality of the female genitalia	C4023820	3	449	6.17866064334e-06	0.0002290292177191329	MYC,F2,FOS
244	Thrombophilia	C0398623	2	125	6.24937537919e-06	0.0002299717247879359	SERPINC1,F2
245	Thyroid cancer, nonmedullary, 4	C0007115	3	453	6.39936337743e-06	0.00023091423185673892	MYC,JUN,FOS
252	Bladder carcinoma	C0699885	4	1087	6.87668747479e-06	0.00023751178133836004	MYC,UBC,JUN,FOS
253	Diabetes Mellitus, Type 1	C0011849	5	2081	6.944861351e-06	0.00023845428840716306	MYC,SERPINC1,F2,SELP,FOS
254	Ventricular Fibrillation Adverse Event	C0232197	2	131	7.19473213306e-06	0.00023939679547596606	F2,SELP
255	Adult T-Cell Lymphoma/Leukemia	C0023493	3	469	7.34095160093e-06	0.0002403393025447691	MYC,JUN,FOS
256	Diabetes mellitus type 1	C0011854	4	1104	7.41981710195e-06	0.0002412818096135721	MYC,SERPINC1,SELP,FOS
257	Hepatocarcinogenesis	C1512409	3	471	7.46548260122e-06	0.00024222431668237512	MYC,JUN,FOS
258	Pneumonia	C0032285	3	471	7.46548260122e-06	0.00024316682375117812	JUN,SELP,FOS
259	Gastrointestinal hemorrhage	C0017181	2	133	7.52973157947e-06	0.00024410933081998117	MYC,F2
260	Abnormality of the pulmonary vasculature	C4025271	2	133	7.52973157947e-06	0.00024505183788878416	SERPINC1,F2
261	Eczema	C0013595	3	474	7.65517957124e-06	0.0002459943449575872	JUN,SELP,FOS
273	Polycystic Ovary Syndrome	C0032460	3	477	7.84851437863e-06	0.00025730442978322336	SERPINC1,F2,FOS
274	Acute myocardial ischemia	C0151744	3	484	8.31363418174e-06	0.00025824693685202636	MYC,F2,SELP
275	Thyroid Neoplasms	C0040136	3	486	8.4501733999e-06	0.00025918944392082946	MYC,SELP,FOS
279	Aortic valve stenosis	C0003507	2	141	8.97295588387e-06	0.0002629594721960415	JUN,FOS
280	Obesity	C0028754	5	2181	9.14081935754e-06	0.0002639019792648445	MYC,F2,JUN,SELP,FOS
281	Lung Neoplasms	C0024121	4	1155	9.25526795903e-06	0.0002648444863336475	MYC,JUN,SELP,FOS
282	Neoplastic Cell Transformation	C0007621	2	144	9.55806206948e-06	0.00026578699340245053	MYC,JUN
283	Monoclonal Gammopathy of Undetermined Significance	C0026470	2	144	9.55806206948e-06	0.0002667295004712535	MYC,JUN
294	Myeloid leukemia	C0023470	3	533	1.21651674857e-05	0.00027709707822808673	MYC,JUN,FOS
295	Stroke	C0038454	4	1229	1.25375011105e-05	0.00027803958529688973	SERPINC1,F2,SELP,FOS
298	Abnormality of the menstrual cycle	C4025888	2	163	1.38579754752e-05	0.00028086710650329877	F2,FOS
299	Albuminuria	C0001925	2	163	1.38579754752e-05	0.00028180961357210176	F2,SELP
303	Dermatitis, Atopic	C0011615	3	567	1.55225219294e-05	0.0002855796418473139	JUN,SELP,FOS
304	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	3	568	1.56305858181e-05	0.0002865221489161169	MYC,JUN,FOS
305	Abnormality of the ovary	C4021818	2	171	1.59952129585e-05	0.0002874646559849199	MYC,FOS
306	Cachexia	C0006625	2	171	1.59952129585e-05	0.0002884071630537229	UBC,SELP
312	Internal hemorrhage	C0333285	2	174	1.68496501559e-05	0.000294062205466541	MYC,F2
313	Nevus	C0497388	2	174	1.68496501559e-05	0.000295004712535344	MYC,FOS
314	Liver Diseases	C0023895	3	586	1.76733860481e-05	0.00029594721960414706	F2,JUN,SELP
315	Bleeding disorder, platelet-type, 21	C0005779	2	177	1.77337787186e-05	0.00029688972667295005	SERPINC1,F2
324	Menstrual irregularities	C0156404	2	180	1.86479217429e-05	0.0003053722902921772	F2,FOS
325	Abnormality of blood and blood-forming tissues	C0241657	4	1335	1.87697678036e-05	0.0003063147973609802	MYC,SERPINC1,F2,FOS
326	Seborheic dermatitis	C0011603	2	181	1.89593751375e-05	0.0003072573044297832	JUN,FOS
327	Familial hypercholesterolemia	C0020445	2	182	1.92743429912e-05	0.0003081998114985862	F2,SELP
331	Melanocytic nevus	C0027962	2	185	2.02397178307e-05	0.00031196983977379835	MYC,FOS
332	Status epilepticus	C0038220	2	185	2.02397178307e-05	0.00031291234684260134	JUN,FOS
333	Malignant tumor of urinary bladder	C0005684	4	1371	2.13664221514e-05	0.00031385485391140433	MYC,UBC,JUN,FOS
339	Abnormality of blood circulation	C4023585	2	189	2.15760164648e-05	0.00031950989632422246	MYC,F2
340	Brain Diseases	C0006111	2	194	2.33265999308e-05	0.00032045240339302546	F2,JUN
345	Chronic hepatitis	C0019189	2	197	2.44205228093e-05	0.00032516493873704054	MYC,F2
346	Breast carcinoma	C0678222	6	4281	2.48598890198e-05	0.00032610744580584353	MYC,F2,UBC,JUN,SELP,FOS
347	Berardinelli-Seip congenital lipodystrophy	C0221032	1	25	2.55378435083e-05	0.0003270499528746466	FOS
348	Neoplasms, Radiation-Induced	C0027666	1	25	2.55378435083e-05	0.0003279924599434496	MYC
349	Leg Ulcer	C0023223	1	25	2.55378435083e-05	0.0003289349670122526	F2
350	Post-transplant lymphoproliferative disorder	C0432487	1	25	2.55378435083e-05	0.0003298774740810556	MYC
351	Spiegler-Brooke syndrome	C1857941	1	25	2.55378435083e-05	0.0003308199811498586	F2
352	Broad foot	C1866241	1	26	2.76616817068e-05	0.00033176248821866166	FOS
353	Brain Hemorrhage, Traumatic	C0553692	1	26	2.76616817068e-05	0.00033270499528746466	F2
354	Acute hepatitis	C0267797	1	26	2.76616817068e-05	0.00033364750235626765	F2
355	Epidermal cyst	C0014511	1	26	2.76616817068e-05	0.00033459000942507065	MYC
356	Plasmablastic lymphoma	C0079746	1	26	2.76616817068e-05	0.00033553251649387375	MYC
357	Thyroid carcinoma	C0549473	3	659	2.80372071225e-05	0.00033647502356267675	MYC,JUN,FOS
358	Malignant lymphoma - lymphoplasmacytic	C0334633	1	27	2.98698882609e-05	0.00033741753063147974	MYC
359	Monoclonal Gammapathies	C1136085	1	27	2.98698882609e-05	0.0003383600377002828	MYC
360	Pulmonary Emphysema	C0034067	2	211	2.99744560238e-05	0.0003393025447690858	JUN,FOS
361	Abnormality of the pancreas	C4025751	2	212	3.04002909408e-05	0.0003402450518378888	MYC,FOS
362	Hypercholesterolemia, autosomal dominant, type B	C0020443	2	212	3.04002909408e-05	0.00034118755890669177	F2,SELP
363	Colorectal cancer	C1527249	5	2681	3.04502961748e-05	0.0003421300659754948	MYC,F2,JUN,SELP,FOS
364	EMG: myopathic abnormalities	C0000768	3	675	3.08047742239e-05	0.0003430725730442978	MYC,SERPINC1,F2
365	Thrombosis of retinal vein	C0035328	1	28	3.21625958586e-05	0.00034401508011310086	F2
366	Early gastric cancer	C0349530	1	28	3.21625958586e-05	0.0003449575871819039	MYC
367	Prominent supraorbital ridges	C1842060	1	28	3.21625958586e-05	0.0003459000942507069	FOS
368	Abnormality of purine metabolism	C4025346	1	28	3.21625958586e-05	0.0003468426013195099	MYC
369	Liposarcoma, Dedifferentiated	C0205824	1	28	3.21625958586e-05	0.0003477851083883129	JUN
370	Choreoacanthocytosis	C0393576	1	28	3.21625958586e-05	0.00034872761545711595	SELP
371	Fulminant hepatitis	C0302809	1	28	3.21625958586e-05	0.00034967012252591894	F2
372	Hepatoblastoma	C0206624	2	220	3.3950912365e-05	0.00035061262959472193	MYC,F2
373	Old myocardial infarction	C0155668	1	29	3.45395620837e-05	0.000351555136663525	F2
374	Pyruvate carboxylase deficiency	C0034341	1	29	3.45395620837e-05	0.00035249764373232803	F2
375	Chromosomal translocation	C0040715	1	29	3.45395620837e-05	0.000353440150801131	MYC
376	Femur Head Necrosis	C0015814	1	29	3.45395620837e-05	0.000354382657869934	F2
377	Recurrent E. coli infections	C0014836	1	29	3.45395620837e-05	0.00035532516493873707	F2
378	Skin cancer	C0007114	2	222	3.48793650914e-05	0.00035626767200754006	JUN,FOS
379	Liver failure acute infantile	C0085605	2	223	3.53498087401e-05	0.00035721017907634306	F2,FOS
380	Abnormality of cardiovascular system physiology	C4023587	3	700	3.55262876225e-05	0.0003581526861451461	MYC,F2,FOS
381	T-Cell Prolymphocytic Leukemia	C0023494	1	30	3.70008894525e-05	0.0003590951932139491	MYC
382	Familial cold-induced inflammatory syndrome 1, 120100 (3)	C0009443	1	30	3.70008894525e-05	0.0003600377002827521	SELP
383	Breast-ovarian cancer, familial 1	C0006142	6	4543	3.7292854401e-05	0.00036098020735155515	MYC,F2,UBC,JUN,SELP,FOS
384	Aortic aneurysm, familial thoracic 11, susceptibility to	C0003486	2	229	3.82603675353e-05	0.0003619227144203582	JUN,FOS
385	Anaplasia	C0002793	2	231	3.92645274115e-05	0.0003628652214891612	MYC,JUN
386	Gingival bleeding	C0017565	1	31	3.9546481204e-05	0.0003638077285579642	F2
387	Chronic leukemia	C1279296	1	31	3.9546481204e-05	0.00036475023562676723	MYC
388	Monocytosis	C0085702	1	31	3.9546481204e-05	0.0003656927426955702	MYC
389	Hemiplegia	C0018991	1	31	3.9546481204e-05	0.0003666352497643732	F2
390	Abnormality of cardiovascular system electrophysiology	C0243050	4	1568	4.10134037239e-05	0.0003675777568331762	MYC,SERPINC1,F2,FOS
391	Lymphoproliferative disorder	C0024314	2	236	4.18505353875e-05	0.00036852026390197926	MYC,F2
392	Familial Alzheimer Disease (FAD)	C0276496	1	32	4.21763820462e-05	0.0003694627709707823	FOS
393	Stenosis	C0678234	1	32	4.21763820462e-05	0.0003704052780395853	F2
394	Philadelphia chromosome positive	C0856536	1	32	4.21763820462e-05	0.00037134778510838836	MYC
395	Oligomenorrhea	C0028949	1	32	4.21763820462e-05	0.00037229029217719135	FOS
396	Puerperal Disorders	C0034040	1	32	4.21763820462e-05	0.00037323279924599435	F2
397	Hemorrhagic disorder due to intrinsic circulating anticoagulants	C0019087	1	32	4.21763820462e-05	0.00037417530631479734	F2
398	Acute myocardial infarction	C0155626	2	237	4.23808928743e-05	0.0003751178133836004	F2,SELP
399	Gastritis	C0017152	2	237	4.23808928743e-05	0.0003760603204524034	JUN,FOS
400	Hypergranular promyelocytic leukemia	C2745900	2	238	4.2915647628e-05	0.0003770028275212064	MYC,FOS
401	Adenocarcinoma of colon	C0338106	2	240	4.39982794197e-05	0.0003779453345900095	MYC,JUN
402	Oestrogen deficiency	C0853662	1	33	4.48903790436e-05	0.0003788878416588125	MYC
403	Medulloblastoma, Childhood	C0278510	1	33	4.48903790436e-05	0.00037983034872761547	MYC
404	Anterior myocardial infarction	C0340293	1	33	4.48903790436e-05	0.00038077285579641846	F2
405	Aggressive Non-Hodgkin Lymphoma	C1332225	1	33	4.48903790436e-05	0.0003817153628652215	MYC
406	Prostatic Neoplasms	C0033578	4	1606	4.60569282643e-05	0.0003826578699340245	MYC,SERPINC1,JUN,FOS
407	Myeloproliferative Disorders	C0027022	2	245	4.67834701434e-05	0.0003836003770028275	MYC,F2
408	Renal hypertension	C0020544	1	34	4.76885743934e-05	0.00038454288407163055	SERPINC1
409	Comedone	C0221228	1	34	4.76885743934e-05	0.00038548539114043355	MYC
410	Paratuberculosis	C0030524	1	34	4.76885743934e-05	0.0003864278982092366	F2
411	Kidney Diseases	C0022658	3	755	4.77718075444e-05	0.0003873704052780396	SERPINC1,F2,FOS
412	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	3	756	4.80197955466e-05	0.00038831291234684264	JUN,SELP,FOS
413	Malignant neoplasm of pancreas	C0346647	4	1625	4.87549273374e-05	0.00038925541941564563	MYC,JUN,SELP,FOS
414	Hepatic encephalopathy	C0019151	1	35	5.05709292564e-05	0.0003901979264844486	F2
415	Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	C3536893	1	35	5.05709292564e-05	0.0003911404335532517	MYC
416	Glioblastoma	C0017636	4	1645	5.17274273126e-05	0.00039208294062205467	MYC,JUN,SELP,FOS
417	Fibrosarcoma	C0016057	2	254	5.20845967393e-05	0.00039302544769085766	JUN,FOS
418	Deficiency of glucose-6-phosphate dehydrogenase	C2939465	1	36	5.35372575476e-05	0.00039396795475966066	F2
419	Complete trisomy 18 syndrome	C0152096	1	36	5.35372575476e-05	0.00039491046182846376	MYC
420	Prolonged bleeding time	C0439590	1	36	5.35372575476e-05	0.00039585296889726676	F2
421	Sarcoidosis	C0036202	2	257	5.39356135856e-05	0.00039679547596606975	JUN,FOS
422	Gastroesophageal reflux	C0017168	2	258	5.45621311947e-05	0.0003977379830348728	JUN,FOS
423	Alveolar Bone Loss	C0002382	1	37	5.65877498586e-05	0.0003986804901036758	SELP
424	Salmonella infections	C0036117	1	37	5.65877498586e-05	0.0003996229971724788	JUN
425	Condylomata Acuminata	C0009663	1	37	5.65877498586e-05	0.0004005655042412818	JUN
426	Mediastinal (Thymic) Large B-Cell Lymphoma	C1292754	1	37	5.65877498586e-05	0.00040150801131008483	MYC
427	Sudden death	C0011071	1	37	5.65877498586e-05	0.0004024505183788878	F2
428	Pancreatic Carcinoma	C0235974	4	1690	5.89364750032e-05	0.0004033930254476909	MYC,JUN,SELP,FOS
429	Lymphoma, AIDS-Related	C0085090	1	38	5.97221063228e-05	0.0004043355325164939	MYC
430	Ovarian hyperstimulation syndrome	C0085083	1	38	5.97221063228e-05	0.0004052780395852969	F2
431	Pregnancy associated hypertension	C0852036	1	38	5.97221063228e-05	0.0004062205466540999	F2
432	End Stage Liver Disease	C0745744	1	38	5.97221063228e-05	0.0004071630537229029	F2
433	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	4	1700	6.06405784243e-05	0.00040810556079170596	MYC,UBC,JUN,FOS
434	Neurobehavioral Manifestations	C0525041	1	39	6.29404873899e-05	0.00040904806786050895	SELP
435	Cerebroretinal microangiopathy with calcifications and cysts 1	C0155765	1	39	6.29404873899e-05	0.00040999057492931195	SELP
436	Abnormality of nucleobase metabolism	C4023643	1	39	6.29404873899e-05	0.00041093308199811505	MYC
437	Pancreatitis, Acute Necrotizing	C0267941	1	39	6.29404873899e-05	0.00041187558906691804	SELP
438	Partial Trisomy	C1297882	1	39	6.29404873899e-05	0.00041281809613572104	MYC
439	Rotavirus Infections	C0035869	1	39	6.29404873899e-05	0.00041376060320452403	JUN
440	Coronary Thrombosis	C0010072	1	39	6.29404873899e-05	0.0004147031102733271	SERPINC1
441	Purpura, Thrombotic Thrombocytopenic	C0034155	1	39	6.29404873899e-05	0.0004156456173421301	F2
442	Intestinal Cancer	C0346627	1	40	6.62427949152e-05	0.00041658812441093307	MYC
443	Neurotoxicity Syndromes	C0235032	1	40	6.62427949152e-05	0.0004175306314797361	FOS
444	Prolymphocytic Leukemia	C0023486	1	40	6.62427949152e-05	0.0004184731385485391	MYC
445	Chronic myeloid leukemia	C0023473	3	822	6.65941745452e-05	0.0004194156456173421	MYC,SELP,FOS
446	Pancreatitis	C0030305	2	277	6.73913439365e-05	0.00042035815268614516	SELP,FOS
447	Squamous cell carcinoma of the head and neck	C1168401	3	825	6.75475438725e-05	0.0004213006597549482	MYC,JUN,FOS
448	Neoplasm of the tongue	C0040411	1	41	6.962901925e-05	0.0004222431668237512	FOS
449	Pneumonia, Bacterial	C0004626	1	41	6.962901925e-05	0.0004231856738925542	F2
450	Acne Vulgaris	C0001144	1	41	6.962901925e-05	0.00042412818096135724	SELP
451	Glanzmann thrombasthenia	C0040015	1	41	6.962901925e-05	0.00042507068803016024	F2
452	Arterial Occlusive Diseases	C0003838	1	41	6.962901925e-05	0.00042601319509896323	F2
453	Acanthosis nigricans	C0000889	1	42	7.30990307509e-05	0.0004269557021677662	FOS
454	Primary malignant neoplasm of brain	C0750979	1	42	7.30990307509e-05	0.00042789820923656933	MYC
455	Cholesteatoma	C0008373	1	43	7.66528187218e-05	0.0004288407163053723	MYC
456	Platelet-type bleeding disorder 15	C0005818	1	43	7.66528187218e-05	0.0004297832233741753	F2
457	Malignant neoplasm of male breast	C0242787	1	43	7.66528187218e-05	0.00043072573044297837	MYC
458	Tumor-Associated Vasculature	C1519666	1	43	7.66528187218e-05	0.00043166823751178136	SERPINC1
459	Leukemia, Plasma Cell	C0023484	1	43	7.66528187218e-05	0.00043261074458058436	MYC
460	Primary central nervous system lymphoma	C0280803	1	44	8.02904578766e-05	0.00043355325164938735	MYC
461	Precursor cell lymphoblastic lymphoma	C0079748	1	44	8.02904578766e-05	0.0004344957587181904	MYC
462	Juvenile myoclonic epilepsy	C0270853	1	44	8.02904578766e-05	0.0004354382657869934	F2
463	Cervical intraepithelial neoplasia grade 1	C0349458	1	44	8.02904578766e-05	0.0004363807728557964	MYC
464	Ocular Hypertension	C0028840	1	44	8.02904578766e-05	0.0004373232799245995	JUN
465	Helicobacter pylori infection	C0850666	2	297	8.28844141459e-05	0.0004382657869934025	JUN,FOS
466	Bone necrosis	C0029445	1	45	8.40117063555e-05	0.0004392082940622055	F2
467	Thromboangiitis Obliterans	C0040021	1	45	8.40117063555e-05	0.0004401508011310085	F2
468	Hyperoxia	C0242706	1	45	8.40117063555e-05	0.0004410933081998115	JUN
469	HELLP Syndrome	C0162739	1	45	8.40117063555e-05	0.0004420358152686145	F2
470	Respiratory Syncytial Virus Infections	C0035235	2	299	8.45509608413e-05	0.0004429783223374175	JUN,FOS
471	Takayasu Arteritis	C0039263	1	46	8.78167536752e-05	0.00044392082940622056	SELP
472	Essential hypertension	C0085580	2	305	8.96822455084e-05	0.00044486333647502356	SERPINC1,SELP
473	Malignant tumor of cervix	C0007847	3	889	9.0379844265e-05	0.0004458058435438266	MYC,JUN,FOS
474	Lupus Vulgaris	C0024131	2	307	9.14369956485e-05	0.0004467483506126296	SERPINC1,F2
475	Abnormal genital system morphology	C4021096	3	892	9.1572932746e-05	0.00044769085768143265	MYC,F2,FOS
476	Choroidal Neovascularization	C0600518	1	47	9.17053585023e-05	0.00044863336475023564	F2
477	Childhood onset	C1837352	1	47	9.17053585023e-05	0.00044957587181903864	F2
478	Isochromosomes	C0242621	1	47	9.17053585023e-05	0.0004505183788878417	MYC
479	Nijmegen Breakage Syndrome	C0398791	1	47	9.17053585023e-05	0.0004514608859566447	MYC
480	Sickle Cell Trait	C0037054	1	47	9.17053585023e-05	0.0004524033930254477	F2
481	Kidney Calculi	C0022650	1	47	9.17053585023e-05	0.00045334590009425067	F2
482	Carcinoma of colon	C0699790	4	1856	9.26035213715e-05	0.00045428840716305377	MYC,JUN,SELP,FOS
483	Hereditary factor IX deficiency disease	C0008533	1	48	9.56775929842e-05	0.00045523091423185677	F2
484	Squamous cell carcinoma of mouth	C0585362	1	48	9.56775929842e-05	0.00045617342130065976	MYC
485	Leiomyoma	C0023267	2	316	9.96123653885e-05	0.0004571159283694628	MYC,FOS
486	Atypical teratoid/rhabdoid tumor	C1266184	1	49	9.97333344878e-05	0.0004580584354382658	MYC
487	Prostate cancer, familial	C2931456	1	49	9.97333344878e-05	0.0004590009425070688	MYC
488	Papillary renal cell carcinoma	C1306837	1	49	9.97333344878e-05	0.0004599434495758718	MYC
489	Abnormality of chromosome stability	C0376628	1	49	9.97333344878e-05	0.00046088595664467484	MYC
490	Hemophilia, NOS	C0684275	1	49	9.97333344878e-05	0.00046182846371347784	F2
491	Rous Sarcoma	C0086942	1	49	9.97333344878e-05	0.0004627709707822809	UBC
492	Anti-Glomerular Basement Membrane Disease	C0403529	1	49	9.97333344878e-05	0.00046371347785108393	SELP
493	Von Willebrand disease, recessive form	C0042974	1	49	9.97333344878e-05	0.00046465598491988693	F2
494	Pleuritis	C0032231	1	49	9.97333344878e-05	0.0004655984919886899	SELP
495	Discoid lupus erythematosus	C0024138	2	319	0.000102440294869	0.0004665409990574929	SERPINC1,F2
496	Abnormal bleeding	C1458140	2	319	0.000102440294869	0.00046748350612629597	MYC,F2
497	Symptomatic human immunodeficiency virus infection	C0019693	4	1900	0.000103652620908	0.00046842601319509896	MYC,JUN,SELP,FOS
498	stage, non-small cell lung cancer	C0280217	1	50	0.00010387271106	0.00046936852026390196	MYC
499	Vascular lesions	C1402315	1	50	0.00010387271106	0.00047031102733270506	MYC
500	Ventricular fibrillation	C0042510	1	50	0.00010387271106	0.00047125353440150805	SELP
501	Arthritis, Reactive	C0085435	1	50	0.00010387271106	0.00047219604147031105	JUN
502	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	4	1913	0.000107106840517	0.00047313854853911404	MYC,JUN,SELP,FOS
503	Malignant neoplasm of female breast	C0235653	1	51	0.000108095485221	0.0004740810556079171	MYC
504	Phyllodes tumor, benign	C0010701	1	51	0.000108095485221	0.0004750235626767201	MYC
505	Pseudoxanthoma elasticum	C0473583	1	51	0.000108095485221	0.0004759660697455231	SELP
506	Nephrosis	C0027720	1	51	0.000108095485221	0.00047690857681432613	F2
507	Accelerated skeletal maturation	C0545053	1	51	0.000108095485221	0.0004778510838831291	FOS
508	Osteosarcoma	C0585442	3	936	0.000110433081742	0.0004787935909519321	MYC,JUN,FOS
509	Osteoarthritis	C0029408	3	942	0.000113209539323	0.00047973609802073517	SERPINC1,JUN,FOS
510	Insulin Resistance	C0021655	2	332	0.000115303102211	0.0004806786050895382	SELP,FOS
511	Leukemia, Large Granular Lymphocytic	C1522378	1	54	0.000121264373579	0.0004816211121583412	FOS
512	Female Breast Carcinoma	C0007104	1	54	0.000121264373579	0.0004825636192271442	MYC
513	Low Grade Squamous Intraepithelial Neoplasia	C1302773	1	54	0.000121264373579	0.00048350612629594725	MYC
514	Hepatitis, Alcoholic	C0019187	1	54	0.000121264373579	0.00048444863336475025	MYC
515	Hepatitis D Infection	C0011226	1	55	0.000125820783776	0.00048539114043355324	MYC
516	Carcinoma breast stage IV	C0278488	2	342	0.000125886624296	0.00048633364750235624	MYC,SELP
517	Secondary hypertriglyceridemia	C0027627	5	3444	0.00012944005729	0.00048727615457115934	MYC,F2,JUN,SELP,FOS
518	Toxic Shock Syndrome	C0600327	1	56	0.000130460357814	0.00048821866163996233	MYC
519	Crohn Disease	C0010346	3	979	0.000131477827409	0.0004891611687087653	F2,JUN,FOS
520	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	2	348	0.000132531844408	0.0004901036757775683	MYC,JUN
521	Abnormality of the genital system	C0744356	3	983	0.00013357449908	0.0004910461828463714	MYC,F2,FOS
522	Hutchinson-Gilford syndrome	C0033300	1	57	0.000135183286634	0.0004919886899151744	FOS
523	Henoch-Schoenlein Purpura	C0034152	1	58	0.000139989326658	0.0004929311969839774	F2
524	Chromosome 8, trisomy	C0008671	1	59	0.000144878584614	0.0004938737040527804	MYC
525	Neoplasm of the parathyroid gland	C0030521	1	59	0.000144878584614	0.0004948162111215835	MYC
526	Supraventricular tachycardia	C0039240	1	60	0.000149850987374	0.0004957587181903864	SERPINC1
527	Gastrointestinal obstruction	C0236124	1	60	0.000149850987374	0.0004967012252591894	MYC
528	Menopause present (finding)	C0150312	1	61	0.00015490646922	0.0004976437323279925	F2
529	Cooley's anemia	C0002875	1	61	0.00015490646922	0.0004985862393967954	F2
530	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	4	2073	0.000157466796913	0.0004995287464655985	MYC,F2,JUN,FOS
531	Invasive breast carcinoma	C0853879	2	369	0.00015759035969	0.0005004712535344015	MYC,JUN
532	Other specified disorders of breast	C0006145	1	62	0.000160044959699	0.0005014137606032046	MYC
533	Epistaxis	C0014591	1	62	0.000160044959699	0.0005023562676720076	F2
534	Arthritis, Rheumatoid	C0003864	3	1030	0.000160087174032	0.0005032987747408106	F2,JUN,FOS
535	Carcinoma of cervix	C0302592	3	1045	0.000169305600693	0.0005042412818096136	MYC,JUN,FOS
536	Trachoma	C0040592	1	64	0.000170571006261	0.0005051837888784167	SELP
537	Early-Stage Breast Carcinoma	C2986665	1	64	0.000170571006261	0.0005061262959472196	MYC
538	Hyperpituitarism	C0020506	1	64	0.000170571006261	0.0005070688030160227	FOS
539	Neoplasms, Germ Cell and Embryonal	C0027658	1	64	0.000170571006261	0.0005080113100848256	MYC
540	Stomach cancer	C0699791	4	2109	0.000170993764452	0.0005089538171536286	MYC,F2,JUN,FOS
541	Ameloblastoma	C0002448	1	65	0.000175958424685	0.0005098963242224317	FOS
542	Hemolytic uremic syndrome	C0019061	1	65	0.000175958424685	0.0005108388312912346	F2
543	Extraosseous Ewings sarcoma-primitive neuroepithelial tumor	C0279980	1	65	0.000175958424685	0.0005117813383600377	MYC
544	Hypertrophic cardiomyopathy	C0007194	2	384	0.000177264056038	0.0005127238454288407	MYC,FOS
545	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	2	385	0.00017862982996	0.0005136663524976437	MYC,SELP
546	Dilatation	C0012359	1	66	0.000181428747637	0.0005146088595664467	SELP
547	Limb ischemia	C2945695	1	66	0.000181428747637	0.0005155513666352498	F2
548	Fibroadenoma of the breast	C0178421	1	66	0.000181428747637	0.0005164938737040527	MYC
549	Leukemia, Lymphocytic, Acute, L1	C0023452	2	388	0.000182768245508	0.0005174363807728559	MYC,SERPINC1
550	aggressive cancer	C2945759	1	67	0.000186981965721	0.0005183788878416589	MYC
551	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	C0034069	2	392	0.000188382936997	0.0005193213949104619	F2,FOS
552	{Systemic lupus erythematosus, susceptibility to, 8} (2)	C0409974	2	393	0.000189804007394	0.0005202639019792649	SERPINC1,F2
553	 Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	C0206081	1	68	0.000192618006599	0.0005212064090480678	FOS
554	Familial adenomatous polyposis 1	C0032580	2	395	0.000192667108529	0.0005221489161168709	MYC,FOS
555	Ovarian epithelial cancer	C0677886	4	2172	0.000196832892803	0.0005230914231856739	MYC,F2,JUN,FOS
556	Lymphocytosis	C0024282	1	69	0.000198336719719	0.0005240339302544769	MYC
557	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	1	69	0.000198336719719	0.0005249764373232799	MYC
558	Giant cell tumor of bone	C0206638	1	69	0.000198336719719	0.000525918944392083	MYC
559	Primary antiphospholipid syndrome	C0085278	1	69	0.000198336719719	0.0005268614514608859	F2
560	Myelodysplastic syndrome	C3463824	2	399	0.000198477643893	0.000527803958529689	MYC,FOS
561	Giant Cell Tumors	C0017525	1	70	0.000204138260586	0.000528746465598492	FOS
562	Acromegaly	C0001206	1	70	0.000204138260586	0.000529688972667295	MYC
563	Bronchiolitis	C0006271	1	70	0.000204138260586	0.000530631479736098	JUN
564	Unipolar Depression	C0041696	2	406	0.000208919193494	0.0005315739868049011	JUN,FOS
565	Familial colorectal cancer	C1333600	1	71	0.000210022448445	0.000532516493873704	MYC
566	Retroviridae Infections	C0035369	1	71	0.000210022448445	0.000533459000942507	MYC
567	Acute Lung Injury	C0242488	1	71	0.000210022448445	0.0005344015080113101	F2
568	Gaucher Disease	C0017205	1	71	0.000210022448445	0.0005353440150801131	F2
569	Well Differentiated Pancreatic Endocrine Tumor	C1337011	1	71	0.000210022448445	0.0005362865221489162	MYC
570	{Atopy, susceptibility to}, 147050 (3)	C0392707	1	71	0.000210022448445	0.0005372290292177191	SELP
571	Abnormality of the oral cavity	C4025887	3	1109	0.000213057840533	0.0005381715362865222	MYC,F2,FOS
572	Hodgkin Disease	C0019829	2	409	0.000213501603519	0.0005391140433553252	MYC,JUN
573	Female infertility	C0021361	1	72	0.000215989329748	0.0005400565504241282	F2
574	Early onset of sexual maturation	C4022392	1	72	0.000215989329748	0.0005409990574929312	FOS
575	Angina pectoris	C0002962	1	73	0.000222038863039	0.0005419415645617343	F2
576	Abnormal enzyme/coenzyme activity	C4022922	1	73	0.000222038863039	0.0005428840716305372	MYC
577	Abnormality of the respiratory system	C4018871	3	1121	0.000222099311619	0.0005438265786993403	SERPINC1,F2,FOS
578	Abnormality of nitrogen compound homeostasis	C4025336	1	74	0.000228170894357	0.0005447690857681433	MYC
579	Granulomatosis with Polyangiitis	C3495801	1	74	0.000228170894357	0.0005457115928369462	F2
580	Embryonal neoplasm	C0027654	1	74	0.000228170894357	0.0005466540999057493	MYC
581	Abnormality of the supraorbital ridges	C4022027	1	74	0.000228170894357	0.0005475966069745522	FOS
582	Abnormality of digestive system physiology	C4293692	3	1132	0.000230630707232	0.0005485391140433553	MYC,F2,FOS
583	Postoperative Complications	C0032787	1	75	0.000234385468228	0.0005494816211121583	F2
584	Pleural Effusion, Malignant	C0080032	1	75	0.000234385468228	0.0005504241281809613	MYC
585	Azotemia	C0242528	1	75	0.000234385468228	0.0005513666352497644	MYC
586	Desmoplastic spindle and epithelioid cell melanocytic nevus of skin	C1511789	1	75	0.000234385468228	0.0005523091423185675	MYC
587	Paroxysmal nocturnal hemoglobinuria	C0024790	1	75	0.000234385468228	0.0005532516493873704	SERPINC1
588	Chronic gastritis	C0085695	1	77	0.000247062170854	0.0005541941564561735	MYC
589	Migraine with aura	C0154723	1	77	0.000247062170854	0.0005551366635249765	F2
590	Acute promyelocytic leukemia	C0023487	2	431	0.000249123211371	0.0005560791705937795	MYC,FOS
591	Protein Deficiency	C0033626	1	78	0.000253524162511	0.0005570216776625825	F2
592	Intestinal obstruction	C0021843	1	78	0.000253524162511	0.0005579641847313856	MYC
593	Retinopathy	C0035309	2	434	0.00025426104833	0.0005589066918001885	SERPINC1,SELP
594	Recurrent abortion	C0000809	1	79	0.000260068508391	0.0005598491988689915	F2
595	Leukemia, Myeloid, Chronic-Phase	C0023474	1	79	0.000260068508391	0.0005607917059377945	MYC
596	Hematuria	C0018965	1	79	0.000260068508391	0.0005617342130065975	FOS
597	Werner syndrome	C0043119	1	80	0.000266695196805	0.0005626767200754006	MYC
598	Substance Withdrawal Syndrome	C0038587	1	80	0.000266695196805	0.0005636192271442035	FOS
599	Cerebral edema	C0006114	1	80	0.000266695196805	0.0005645617342130066	F2
600	Chronic Lymphocytic Leukemia	C0023434	3	1176	0.0002671660398	0.0005655042412818096	MYC,SELP,FOS
601	Polycythemia	C0032461	1	81	0.000273404215305	0.0005664467483506126	F2
602	Coronary artery stenosis	C0242231	1	81	0.000273404215305	0.0005673892554194156	F2
603	Stable angina	C0340288	1	82	0.000280195527395	0.0005683317624882188	SELP
604	Cystic Fibrosis	C0010674	2	451	0.000284683384084	0.0005692742695570217	JUN,FOS
605	Papillary thyroid carcinoma	C0238463	2	451	0.000284683384084	0.0005702167766258248	MYC,FOS
606	Meningioma	C0025286	2	452	0.000286543109402	0.0005711592836946278	MYC,FOS
607	Infarction, Middle Cerebral Artery	C0740392	1	83	0.000287069118477	0.0005721017907634307	FOS
608	Chlamydia Infections	C0008149	1	83	0.000287069118477	0.0005730442978322338	SELP
609	Iron Overload	C0282193	1	83	0.000287069118477	0.0005739868049010367	F2
610	High-Grade Squamous Intraepithelial Lesions	C0333875	1	83	0.000287069118477	0.0005749293119698398	MYC
611	Carcinoma, Lewis Lung	C0243038	1	83	0.000287069118477	0.0005758718190386428	F2
612	Lichen Planus, Oral	C0206139	1	83	0.000287069118477	0.0005768143261074458	MYC
613	Other disorders of the nervous system	C0027765	2	454	0.000290286274594	0.0005777568331762488	F2,FOS
614	Hepatitis C, Chronic	C0524910	2	455	0.000292169663261	0.0005786993402450519	F2,FOS
615	Precancerous Conditions	C0032927	2	455	0.000292169663261	0.0005796418473138548	MYC,FOS
616	Intestinal polyp	C0021846	1	84	0.000294024720895	0.0005805843543826579	JUN
617	Amphetamine-Related Disorders	C0236733	1	84	0.000294024720895	0.0005815268614514609	FOS
618	Alveolar rhabdomyosarcoma	C0206655	1	84	0.000294024720895	0.0005824693685202638	MYC
619	Hyperglycemia	C0020456	2	459	0.000299783047619	0.0005834118755890669	JUN,FOS
620	Melanoma	C0025202	4	2386	0.000308018107792	0.0005843543826578699	MYC,F2,JUN,FOS
621	Mucinous Adenocarcinoma	C0007130	1	86	0.000308182537429	0.000585296889726673	MYC
622	Liver regeneration disorder	C1318485	1	87	0.000315384590187	0.000586239396795476	MYC
623	Familial Mediterranean fever	C0031069	1	87	0.000315384590187	0.000587181903864279	F2
624	Functional abnormality of the gastrointestinal tract	C4022755	2	470	0.000321382742778	0.000588124410933082	MYC,F2
625	Multiple Sclerosis, Relapsing-Remitting	C0751967	1	88	0.000322668693331	0.0005890669180018851	MYC
626	Abnormality of the coronary arteries	C0158623	1	88	0.000322668693331	0.000590009425070688	FOS
627	Multiple Myeloma	C0026764	3	1236	0.000323568489295	0.0005909519321394911	MYC,JUN,SELP
628	Plasmacytoma	C0032131	1	89	0.000330034664512	0.0005918944392082941	MYC
629	Thyroid associated opthalmopathies	C0339143	1	90	0.000337482690175	0.0005928369462770971	MYC
630	Storage in hepatocytes	C0337174	1	90	0.000337482690175	0.0005937794533459001	FOS
631	High-Grade Prostatic Intraepithelial Neoplasia	C1168327	1	90	0.000337482690175	0.0005947219604147032	MYC
632	Lipid accumulation in hepatocytes	C1837257	1	90	0.000337482690175	0.0005956644674835061	FOS
633	Actinic keratosis	C0022602	1	91	0.000345012591192	0.0005966069745523091	MYC
634	Dermatosis NOS	C0037274	2	483	0.000348184708506	0.0005975494816211122	F2,SELP
635	Sporadic	C0205422	1	92	0.000352624442408	0.0005984919886899151	MYC
636	Puberty and gonadal disorders	C0034011	2	488	0.000358867535339	0.0005994344957587182	F2,FOS
637	Elevated pulmonary artery pressure	C3805917	1	93	0.000360318114129	0.0006003770028275211	FOS
638	Abnormality of pulmonary circulation	C4280730	1	93	0.000360318114129	0.0006013195098963242	FOS
639	Lymphedema, primary, with myelodysplasia	C0024236	1	93	0.000360318114129	0.0006022620169651273	MYC
640	Major depressive disorder	C1269683	2	489	0.000361029275478	0.0006032045240339303	JUN,FOS
641	Chronic ulcerative colitis	C2919828	1	94	0.000368093483238	0.0006041470311027333	F2
642	Merkel cell carcinoma	C0007129	1	94	0.000368093483238	0.0006050895381715364	MYC
643	Bruising susceptibility	C0009938	1	94	0.000368093483238	0.0006060320452403393	F2
644	Inflammatory Breast Carcinoma	C0278601	1	94	0.000368093483238	0.0006069745523091424	MYC
645	Alcohol abuse	C0085762	1	95	0.000375950651132	0.0006079170593779454	F2
646	Hyperlipidemia, familial combined	C0020474	1	95	0.000375950651132	0.0006088595664467483	SELP
647	Cerebral palsy, spastic quadriplegic, 3	C0007789	1	95	0.000375950651132	0.0006098020735155514	F2
648	Combined Hepatocellular Carcinoma and Cholangiocarcinoma	C0221287	2	497	0.000378628852675	0.0006107445805843544	MYC,SERPINC1
649	Peripheral Arterial Diseases	C1704436	1	96	0.000383889550435	0.0006116870876531574	F2
650	Multiple tumors	C0260037	1	96	0.000383889550435	0.0006126295947219604	MYC
651	Generalized hirsutism	C1849211	1	97	0.000391910172026	0.0006135721017907634	FOS
652	Uterine Corpus Cancer	C0153574	2	506	0.000399083852973	0.0006145146088595664	MYC,FOS
653	Malignant neoplasm of endometrium	C0007103	2	506	0.000399083852973	0.0006154571159283695	MYC,FOS
654	Abnormality of the mouth	C0026633	3	1308	0.000402153062162	0.0006163996229971724	MYC,F2,FOS
655	Severe Acute Respiratory Syndrome	C1175175	1	99	0.000408196183003	0.0006173421300659755	F2
656	SUDDEN INFANT DEATH SYNDROME	C0038644	1	99	0.000408196183003	0.0006182846371347785	FOS
657	Hemochromatosis	C0018995	1	99	0.000408196183003	0.0006192271442035816	F2
658	Spastic syndrome	C0270814	1	100	0.00041646158071	0.0006201696512723846	MYC
659	Leukemia, B-Cell	C2004493	1	100	0.00041646158071	0.0006211121583411877	MYC
660	Colorectal cancer 1	C0009402	4	2543	0.000416743522431	0.0006220546654099906	MYC,F2,JUN,FOS
661	Abnormal vascular physiology	C4022603	1	101	0.000424808509478	0.0006229971724787936	FOS
662	Intraocular pressure disorder	C0595921	1	102	0.000433236933028	0.0006239396795475967	SELP
663	Myelofibrosis	C0026987	1	102	0.000433236933028	0.0006248821866163996	SELP
664	Acute leukemia	C0085669	2	525	0.000444592126327	0.0006258246936852027	MYC,F2
665	Neuroectodermal neoplasm	C0206093	1	104	0.000450338008022	0.0006267672007540056	MYC
666	Hyperhidrosis	C0020458	1	104	0.000450338008022	0.0006277097078228087	FOS
667	NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	C0221198	1	105	0.000459010638878	0.0006286522148916117	F2
668	precancerous lesions	C0940937	1	106	0.000467764629738	0.0006295947219604147	MYC
669	Thrombocytosis, benign familial microcytic	C0836924	1	106	0.000467764629738	0.0006305372290292177	SELP
670	Congenital chromosomal disease	C0008626	2	537	0.0004749963289	0.0006314797360980208	MYC,JUN
671	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	C0023485	1	107	0.000476599888238	0.0006324222431668237	MYC
672	Middle Cerebral Artery Occlusion	C0740391	1	107	0.000476599888238	0.0006333647502356267	SELP
673	Teratoma	C0039538	1	108	0.000485516398059	0.0006343072573044298	MYC
674	Depressive Disorder	C0011581	2	543	0.000490690484752	0.0006352497643732327	JUN,SELP
675	tumor vasculature	C1658953	1	109	0.000494514092206	0.0006361922714420359	SELP
676	Mandibular prognathia	C0399526	1	109	0.000494514092206	0.0006371347785108389	FOS
677	Vascular neoplasm	C0282607	1	109	0.000494514092206	0.0006380772855796419	MYC
678	Xenograft Model	C1520166	2	551	0.000512133235208	0.0006390197926484449	MYC,SELP
679	Neoplasm of the adrenal gland	C0001624	1	111	0.000512753047972	0.0006399622997172479	MYC
680	Idiopathic thrombocytopenic purpura	C0398650	1	111	0.000512753047972	0.0006409048067860509	SELP
681	Recurrent fractures	C0016655	1	112	0.000521994120635	0.000641847313854854	FOS
682	early pregnancy	C0747845	1	114	0.000540719494079	0.0006427898209236569	F2
683	Renal cell carcinoma, nonpapillary	C0007134	3	1418	0.000547796881568	0.00064373232799246	MYC,F2,JUN
684	Acquired long QT syndrome	C0023976	1	115	0.000550203692218	0.000644674835061263	MYC
685	Abnormality of pancreas physiology	C4023048	1	115	0.000550203692218	0.0006456173421300659	FOS
686	Abnormality of the glomerulus	C4025889	1	115	0.000550203692218	0.000646559849198869	FOS
687	Ovarian cyst	C0029927	1	116	0.000559768826661	0.000647502356267672	FOS
688	Nephrolithiasis	C0392525	1	116	0.000559768826661	0.000648444863336475	F2
689	Hereditary hyperhomocysteinemia	C0598608	1	116	0.000559768826661	0.000649387370405278	F2
690	Immunodeficiency due to defect in CD3-gamma	C0021051	2	571	0.000568370930566	0.0006503298774740811	MYC,FOS
691	Immediate hypersensitivity	C0020523	1	117	0.00056941482866	0.000651272384542884	SELP
692	Cocaine-Related Disorders	C0236736	1	117	0.00056941482866	0.0006522148916116871	FOS
693	Varicose Veins	C0042345	1	119	0.000588949419019	0.0006531573986804901	F2
694	Xeroderma pigmentosum, group E	C0043346	1	119	0.000588949419019	0.0006540999057492932	MYC
695	Hypertriglyceridemia	C0020557	1	119	0.000588949419019	0.0006550424128180962	FOS
696	Precocious puberty	C0034013	1	120	0.000598838012181	0.0006559849198868992	FOS
697	Squamous cell carcinoma of tongue	C0349566	1	120	0.000598838012181	0.0006569274269557022	MYC
698	Skeletal muscle hypertrophy	C2265792	1	120	0.000598838012181	0.0006578699340245053	FOS
699	Asthma	C0004096	3	1454	0.000602815527278	0.0006588124410933082	JUN,SELP,FOS
700	Primary Effusion Lymphoma	C1292753	1	121	0.000608807229122	0.0006597549481621112	MYC
701	Esophageal carcinoma	C0152018	2	585	0.000610020090858	0.0006606974552309143	MYC,SERPINC1
702	Malnutrition	C0162429	1	122	0.000618857201589	0.0006616399622997172	SERPINC1
703	Abnormal insulin level	C4073160	1	123	0.000628987886744	0.0006625824693685203	FOS
704	Abnormal circulating insulin level	C4073161	1	123	0.000628987886744	0.0006635249764373233	FOS
705	Urticaria	C0042109	1	124	0.000639199137285	0.0006644674835061263	SELP
706	Classical Hodgkin's Lymphoma	C1333064	1	126	0.000659863388243	0.0006654099905749293	MYC
